American Society of Clinical Oncology

SHERPA: White

People

  1. Motzer
    Motzer
  2. Feldman
    Feldman
  3. Bosl
    Bosl
  4. Bajorin
    Bajorin
  5. Voss
    Voss
  6. Sheinfeld
    Sheinfeld
  7. Knezevic
    Knezevic
  8. Reuter
    Reuter
  9. Funt
    Funt
  10. Carlo
    Carlo

Groups

  1. Biostatistics Service (57)
  2. Department of Medicine (57)
  3. Epidemiology and Biostatistics (57)
  4. Genitourinary Oncology Service (57)
  5. Solid Tumor Oncology Division (57)
  6. Survivorship Research (27)
  7. Surgery (25)
  8. Urology (25)
  9. Body Imaging Service (18)
  10. Radiology, Department of (18)
Search Within
  1. "Sujata Patil"
  2. "Robert Motzer"
Formats
  1. Meeting Abstract (50)
  2. Journal Article (7)
Groups
  1. Biostatistics Service (57)
  2. Department of Medicine (57)
  3. Epidemiology and Biostatistics (57)
  4. Genitourinary Oncology Service (57)
  5. Solid Tumor Oncology Division (57)
  6. Survivorship Research (27)

More Groups

People
  1. Robert Motzer (57)
  2. Sujata Patil (57)
  3. Darren Feldman (48)
  4. George Bosl (22)
  5. Dean Bajorin (20)
  6. Martin Voss (20)

More People

Years
  1. 2021 (4)
  2. 2020 (3)
  3. 2019 (6)
  4. 2018 (7)
  5. 2017 (1)
  6. 2016 (3)

More Years

Publications
  1. Journal of Clinical Oncology (56)
  2. JCO Precision Oncology (1)

Results (57)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Immunity to childhood vaccines following high dose chemotherapy (HDCT) and autologous stem cell transplantation (ASCT) for germ cell tumors (GCT) with comparison to Hodgkin lymphoma (HL)
    Meeting Abstract

    Feldman, D. R.; Lewis, A. R.; Knezevic, A.; Ali, D.; Bromberg, M.; Aronson, J.; Funt, S. A.; McHugh, D. J.; Motzer, R. J.; Bajorin, D. F.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Evaluation of germline genetic testing criteria in early-onset kidney cancer
    Meeting Abstract

    Truong, H.; Sheikh, R.; Kotecha, R.; Kemel, Y.; Khurram, A.; Reisz, P.; Lenis, A. T.; Joseph, V.; Mandelker, D.; Lee, C. H.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Paclitaxel, ifosfamide & cisplatin (TIP) as second-line therapy for germ cell tumors (GCT):Long-term follow-up and expansion cohort
    Meeting Abstract

    Gleeson, J. P.; Knezevic, A.; Bromberg, M.; Patil, S.; Sheinfeld, J.; Carver, B. S.; Jones, D. R.; Bains, M. S.; Bajorin, D. F.; Bosl, G. J.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • A pilot study of preoperative nivolumab in high-risk nonmetastatic renal cell carcinoma
    Meeting Abstract

    Carlo, M. I.; Attalla, K.; Patil, S.; Murray, S. J.; Chen, Y. B.; Kotecha, R.; Durack, J. C.; Motzer, R. J.; Hakimi, A. A.; Voss, M. H.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Impact of treatment line on outcomes with salvage ipilimumab plus nivolumab in metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Kotecha, R.; Lee, C. H.; Knezevic, A.; Shah, N. J.; Carlo, M. I.; Feldman, D. R.; Patil, S.; Motzer, R. J.; Voss, M. H.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Detailed evaluation of hearing loss (HL) associated with high-dose (HD) carboplatin for salvage treatment of germ cell tumors (GCT)
    Meeting Abstract

    Feldman, D. R.; Knezevic, A.; Wilson, K.; Bromberg, M.; Budnick, A.; McHugh, D. J.; Larsen, E.; Bajorin, D. F.; Motzer, R. J.; Tonorezos, E. S.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Adjuvant chemotherapy with etoposide plus cisplatin for patients with pathologic stage II nonseminomatous germ cell tumors
    Journal Article

    McHugh, D. J.; Funt, S. A.; Silber, D.; Knezevic, A.; Patil, S.; O'Donnell, D.; Tsai, S.; Reuter, V. E.; Sheinfeld, J.; Carver, B. S.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Comprehensive genomic analysis of metastatic non–clear-cell renal cell carcinoma to identify therapeutic targets
    Journal Article

    Carlo, M. I.; Khan, N.; Zehir, A.; Patil, S.; Ged, Y.; Redzematovic, A.; Coskey, D. T.; Hyman, D. M.; Ladanyi, M.; Chen, Y. B.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Association of body mass index (BMI) with clinical outcomes in 203 metastatic clear cell renal cell carcinoma (ccRCC) patients (pts) treated with immuno-oncology (IO) agents
    Meeting Abstract

    Ged, Y.; Lee, C. H.; Sanchez, A.; Duzgol, C.; Chaim, J.; Carlo, M. I.; Foster, A.; Akin, O.; Feldman, D. R.; Hakimi, A. A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Systemic therapy for advanced clear cell renal cell carcinoma (ccRCC) after progression on immune-oncology plus VEGF targeted therapy combinations (IO-VEGF)
    Meeting Abstract

    Ged, Y.; Gupta, R.; Duzgol, C.; Shapnik, N.; Redzematovic, A.; Kotecha, R.; Voss, M. H.; Feldman, D. R.; Akin, O.; Patil, S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save